No cures: “...cancer industrial complex” is in part a familiar story of a captured regulator that draws much of its funding from the industry it’s supposed to monitor. In exchange for drug companies and medical device makers paying fees that now bring in almost half of the FDA’s $7 billion annual budget, Congress effectively has handed them ever-more ways to shorten testing and get priority treatment from agency reviewers.

https://www.bloomberg.com/graphics/2025-cance...f=yPqYBv4Q